Literature DB >> 9529278

Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.

C K Ng1, R Soufer, P H McNulty.   

Abstract

UNLABELLED: This study was performed to evaluate the effect of insulin on myocardial kinetics of 18F-fluorodeoxyglucose (FDG) and glucose in patients with ischemic heart disease.
METHODS: Twelve male patients (age range 54-79 yr; mean age 69 +/- 8 yr) were studied during the fasting awake state. Patients with diabetes and previous myocardial infarction of the left anterior descending vascular bed were excluded from the study. Patients were injected with a 185-MBq (5-mCi) bolus of FDG during arterial and coronary sinus catheterization. Thirty minutes after FDG injection, paired basal arterial and coronary sinus blood samples were taken for the measurement of FDG and glucose uptake. Thereafter, a primed (100 mU x m(-2) x min(-1) for 10 min) continuous (50 mU x m(-2) x min(-1) infusion of insulin was administered for 60 min using the euglycemic clamp technique, and blood samples were repeated. Blood samples also were taken periodically for the measurement of arterial free fatty acids and insulin.
RESULTS: Euglycemic insulin infusion lowered arterial concentrations of free fatty acids, reducing myocardial extraction of free fatty acids by 85% and stimulated uptake of glucose and FDG. Myocardial glucose and FDG extraction fractions (%) increased from 1 +/- 1 and 2 +/- 2 at baseline to 8 +/- 2 and 10 +/- 3 during insulin infusion, respectively. The lumped constant value was estimated to be 1.44 +/- 0.14 (r = 0.87) for the fasted state, 0.99 +/- 0.07 (r = 0.74) during insulin infusion and 1.00 +/- 0.05 (r = 0.92) when both groups of data were pooled together.
CONCLUSION: The data obtained in this study show that FDG uptake quantitatively traces glucose uptake during physiological hyperinsulinemia in patients with ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529278

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

Review 1.  Tracer kinetic modeling in nuclear cardiology.

Authors:  T R DeGrado; S R Bergmann; C K Ng; D M Raffel
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Quantitative fluorine 18 deoxyglucose uptake by myocardial positron emission tomography in rats.

Authors:  Nobuhiro Handa; Yasuhiro Magata; Eiji Tadamura; Takahiro Mukai; Takeshi Nishina; Senri Miwa; Yutaka Sakakibara; Takuya Nomoto; Junji Konishi; Kazunobu Nishimura; Masashi Komeda
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

3.  Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy.

Authors:  Kira Q Stolen; Jukka Kemppainen; Kari K Kalliokoski; Matti Luotolahti; Tapio Viljanen; Pirjo Nuutila; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

4.  Assessment of insulin resistance in fructose-fed rats with 125I-6-deoxy-6-iodo-D-glucose, a new tracer of glucose transport.

Authors:  Pascale Perret; Lotfi Slimani; Arnaud Briat; Danièle Villemain; Serge Halimi; Jacques Demongeot; Daniel Fagret; Catherine Ghezzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-12-15       Impact factor: 9.236

5.  Role of insulin resistance in heart and skeletal muscle F-18 fluorodeoxyglucose uptake in patients with non-insulin-dependent diabetes mellitus.

Authors:  I Yokoyama; K Yonekura; T Ohtake; H Kawamura; A Matsumoto; Y Inoue; T Aoyagi; S Sugiura; M Omata; K Ohtomo; R Nagai
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

6.  Myocardial glucose uptake in patients with the m.3243A > G mutation in mitochondrial DNA.

Authors:  Markus M Lindroos; Jussi P Pärkkä; Markku T Taittonen; Patricia Iozzo; Mikko Kärppä; Ilmo E Hassinen; Juhani Knuuti; Pirjo Nuutila; Kari Majamaa
Journal:  J Inherit Metab Dis       Date:  2015-06-26       Impact factor: 4.982

7.  Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.

Authors:  Haruhisa Shirasaki; Akira Nakano; Hiroyasu Uzui; Yoshiharu Yonekura; Hidehiko Okazawa; Takanori Ueda; Jong-Dae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

8.  Myocardial and skeletal muscle glucose uptake during exercise in humans.

Authors:  Jukka Kemppainen; Toshihiko Fujimoto; Kari K Kalliokoski; Tapio Viljanen; Pirjo Nuutila; Juhani Knuuti
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

9.  Myocardial glucose utilisation in type II diabetes mellitus patients treated with sulphonylurea drugs.

Authors:  Ikuo Yokoyama; Yusuke Inoue; Toshiyuki Moritan; Kuni Ohtomo; Ryozo Nagai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-10       Impact factor: 9.236

10.  Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis.

Authors:  Rumman Langah; Kenneth Spicer; Mulugeta Gebregziabher; Leonie Gordon
Journal:  J Nucl Cardiol       Date:  2009-06-23       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.